LAB News and Press, Standard BioTools Inc. From 02/24/26

BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025. Recent Highlights: Fourth quarter 2025 revenu...

BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq:...

2026-01-30 09:34:08 ET More on Illumina Illumina: What Is Next In This Sequence? Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close, excluding potential future earnouts, to fuel inorganic growth strategy  ...

2026-01-08 07:40:16 ET Standard BioTools ( LAB ) announced preliminary revenue results for the fourth quarter and full year 2025, expects Q4 revenue of about $56 million, with $24 million from continuing operations vs. consensus of $18.50M.... Read the full article...

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue results for the fourth quarter and full year 2025. Standard BioTools expects fourth quarter 2025 comb...

2025-12-28 09:02:58 ET Shares of life sciences instrument concern Standard BioTools Inc. ( LAB ) have rallied some 20% since its 3Q25 financial report on November 4, 2025, while it awaits the close of its SomaScan sale in 1H26. The prime reason for the rally has been buying from...

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility Molecular Instruments ® (MI), the inventor of the HCR™ imaging platform, and Standard BioTools Inc . (NASDAQ: LAB) today announced a stra...

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks PR Newswire Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution d...

2025-11-04 16:43:12 ET Standard BioTools press release ( LAB ): Q3 GAAP EPS of -$0.09 misses by $0.03 . Revenue of $19.55M (-56.5% Y/Y) beats by $1.55M . For fiscal year 2025, the Company continues to expect combined revenue in the range of $165 million to $175...